Skip to content

Drug interactions

Arformoterol + Flecainide

Severity: Moderate

Arformoterol and Flecainide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Arformoterol, a long-acting beta2 agonist, may cause hypokalemia, tachycardia and QT prolongation, which can add to the proarrhythmic risk of flecainide. Patients with heart disease are most vulnerable.

What this interaction means in plain words

Arformoterol and Flecainide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Arformoterol belongs to Respiratory; Flecainide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Additive proarrhythmic effects via QT prolongation and beta2-mediated hypokalemia.

What to do

Monitor ECG and serum potassium and magnesium. Correct electrolyte disturbances and report palpitations or syncope.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Flecainide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Arformoterol with Flecainide?

MediHelp rates the interaction as moderate. Arformoterol and Flecainide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Arformoterol, a long-acting beta2 agonist, may cause hypokalemia, tachycardia and QT prolongation, which can add to the proarrhythmic risk of flecainide. Patients with heart disease are most vulnerable.

How serious is the interaction between Arformoterol and Flecainide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium and magnesium. Correct electrolyte disturbances and report palpitations or syncope.

What other medicines interact with Flecainide?

MediHelp also lists interactions of Flecainide with, for example, Nirmatrelvir, Nirmatrelvir / ritonavir, Pimozide. The full list is on the Flecainide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in